EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-MetaanalyseOpen Access · CC BY 4.0

Timing of multivessel revascularization in stable patients with STEMI: a systematic review and network meta-analysis

Felix Voll, Constantin Kuna, Maria Scalamogna, Thorsten Kessler, Sebastian Kufner, Tobias Rheude, Hendrik B Sager, Erion Xhepa, Jens Wiebe, Michael Joner, Robert A Byrne, Heribert Schunkert und 4 weitere

Revista Española de Cardiología (English Edition) · 2025

DOI: 10.1016/j.rec.2024.06.002 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Revista Española de Cardiología (English Edition), 2025. Verfasst von Felix Voll und 15 weiteren Autor:innen. Beteiligte Einrichtung: Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, Coronary Artery Disease, Myocardial Revascularization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: Multivessel percutaneous coronary intervention (MV-PCI) is recommended in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (CAD) without cardiogenic shock. The present network meta-analysis investigated the optimal timing of MV-PCI in this context. METHODS: We pooled the aggregated data from randomized trials investigating stable STEMI patients with multivessel CAD treated with a strategy of either MV-PCI or culprit vessel-only PCI. The primary outcome was all-cause death. The main secondary outcomes were cardiovascular death, myocardial infarction, and unplanned ischemia-driven revascularization. RESULTS: Among 11 trials, a total of 10 507 patients were randomly assigned to MV-PCI (same sitting, n=1683; staged during the index hospitalization, n=3460; staged during a subsequent hospitalization within 45 days, n=3275) or to culprit vessel-only PCI (n=2089). The median follow-up was 18.6 months. In comparison with culprit vessel-only PCI, MV-PCI staged during the index hospitalization significantly reduced all-cause death (risk ratio, 0.73; 95%CI, 0.56-0.92; P=.008) and ranked as possibly the best treatment option for this outcome compared with all other strategies. In comparison with culprit vessel-only PCI, a MV-PCI reduced cardiovascular mortality without differences dependent on the timing of revascularization. MV-PCI within the index hospitalization, either in a single procedure or staged, significantly reduced myocardial infarction and unplanned ischemia-driven revascularization, with no significant difference between each other. CONCLUSIONS: In patients with STEMI and multivessel CAD without cardiogenic shock, multivessel PCI within the index hospitalization, either in a single procedure or staged, represents the safest and most efficacious approach. The different timings of multivessel PCI did not result in any significant differences in all-cause death. This study is registered at PROSPERO (CRD42023457794).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ST Elevation Myocardial InfarctionPercutaneous Coronary InterventionCoronary Artery DiseaseMyocardial RevascularizationHumansTime FactorsRandomized Controlled Trials as TopicGlobal Health

Stichwörter der Autor:innen

Coronary artery diseaseEnfermedad coronariaInfarto de miocardioIntervención coronaria percutáneaMeta-analysisMetanálisisMultivasoMultivesselMyocardial infarctionPercutaneous coronary intervention

Autor:innen und Institutionen

  • Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
  • Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Munich, Germany.
  • Cardiovascular Research Institute Dublin and Department of Cardiology, Mater Private Network, Dublin, Ireland; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons of Ireland University of Medicine an…
  • Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.
  • Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany. Electronic address: cassese@dhm.mhn.de.

Zitieren

APA

Voll, F., Kuna, C., Scalamogna, M., Kessler, T., Kufner, S., Rheude, T., Sager, H. B., Xhepa, E., Wiebe, J., Joner, M., Byrne, R. A., Schunkert, H., Ndrepepa, G., Stähli, B. E., Kastrati, A., & Cassese, S. (2025). Timing of multivessel revascularization in stable patients with STEMI: a systematic review and network meta-analysis. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2024.06.002

Vancouver

Voll F, Kuna C, Scalamogna M, Kessler T, Kufner S, Rheude T, et al. Timing of multivessel revascularization in stable patients with STEMI: a systematic review and network meta-analysis. Revista Española de Cardiología (English Edition). 2025. doi:10.1016/j.rec.2024.06.002

BibTeX
@article{Voll2025,
  author = {Voll, Felix and Kuna, Constantin and Scalamogna, Maria and Kessler, Thorsten and Kufner, Sebastian and Rheude, Tobias and Sager, Hendrik B and Xhepa, Erion and Wiebe, Jens and Joner, Michael and Byrne, Robert A and Schunkert, Heribert and Ndrepepa, Gjin and Stähli, Barbara E and Kastrati, Adnan and Cassese, Salvatore},
  title = {Timing of multivessel revascularization in stable patients with STEMI: a systematic review and network meta-analysis},
  journal = {Revista Española de Cardiología (English Edition)},
  year = {2025},
  doi = {10.1016/j.rec.2024.06.002}
}
Kostenlos starten →